Hemofil M (Antihemophilic factor [human], method M, monoclonal purified) for Hemophilia | MyHemophiliaTeam

Connect with others who understand.

sign up log in
About MyHemophiliaTeam
Powered By

Hemofil M is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in people with factor VIII deficiency due to hemophilia A. The technical name of Hemofil M is Antihemophilic factor (human), method M, monoclonal purified.

Hemofil M is a clotting factor. Clotting factors work by supplying proteins missing in people with hemophilia.

How do I take it?
Prescribing information states that Hemofil M is given as an intravenous injection.

Hemofil M comes dried in single-use vials that must be reconstituted before injection.

Side effects
The FDA-approved label for Hemofil M lists common side effects including fever, headache, dizziness, a strange taste in the mouth, and infusion site inflammation.

Serious side effects listed for Hemofil M include life-threatening hypersensitivity reactions and the development of inhibitors.

For more details about this treatment, visit:

Hemofil M prescribing information (PDF) - Shire

Treatment of Hemophilia - Hemophilia Federation of America

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of Use and Privacy Policy.
Already a Member? Log in